Steven Romick - First Pacific Advisors,
Holding/activity history for CVS Health Corp. (CVS)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2018 Q3 | 0 | 0.00 | Sell 100.00% | 0.02 | SEC | ||
| 2018 Q2 | 52,660 | 0.02 | $64.36 | $3,389,000 | SEC | ||
| 2018 Q1 | 52,660 | 0.03 | Reduce 14.46% | <0.01 | $62.21 | $3,276,000 | SEC |
| 2017 Q4 | 61,560 | 0.03 | Reduce 85.50% | 0.24 | $72.50 | $4,463,000 | SEC |
| 2017 Q3 | 424,652 | 0.28 | Reduce 1.95% | <0.01 | $81.32 | $34,533,000 | SEC |
| 2017 Q2 | 433,092 | 0.28 | Add 164.76% | 0.17 | $80.46 | $34,847,000 | SEC |
| 2017 Q1 | 163,580 | 0.11 | Add 1.10% | <0.01 | $78.50 | $12,841,000 | SEC |
| 2016 Q4 | 161,800 | 0.11 | Add 23.01% | 0.02 | $78.91 | $12,768,000 | SEC |
| 2016 Q3 | 131,530 | 0.10 | Add 15.19% | 0.01 | $88.99 | $11,705,000 | SEC |
| 2016 Q2 | 114,190 | 0.10 | Add 7.58% | <0.01 | $95.74 | $10,933,000 | SEC |
| 2016 Q1 | 106,140 | 0.10 | Reduce 16.62% | 0.02 | $103.73 | $11,010,000 | SEC |
| 2015 Q4 | 127,300 | 0.12 | Reduce 81.32% | 0.47 | $97.77 | $12,446,000 | SEC |
| 2015 Q3 | 681,570 | 0.58 | Reduce 85.25% | 3.43 | $96.48 | $65,758,000 | SEC |
| 2015 Q2 | 4,621,500 | 4.02 | Reduce 0.17% | <0.01 | $104.88 | $484,703,000 | SEC |
| 2015 Q1 | 4,629,500 | 4.04 | Reduce 32.76% | 1.76 | $103.21 | $477,811,000 | SEC |
| 2014 Q4 | 6,885,500 | 5.37 | Reduce 8.99% | 0.46 | $96.31 | $663,143,000 | SEC |
| 2014 Q3 | 7,565,900 | 5.15 | Add 0.92% | 0.05 | $79.59 | $602,170,000 | SEC |
| 2014 Q2 | 7,497,100 | 4.73 | Add 0.35% | 0.02 | $75.37 | $565,057,000 | SEC |
| 2014 Q1 | 7,470,700 | 5.05 | Add 0.26% | 0.01 | $74.86 | $559,257,000 | SEC |
| 2013 Q4 | 7,451,000 | 5.18 | Add 1.14% | 0.06 | $71.57 | $533,268,000 | SEC |
| 2013 Q3 | 7,367,300 | 4.47 | Add 0.13% | <0.01 | $56.75 | $418,095,000 | SEC |
| 2013 Q2 | 7,357,900 | 4.65 | Add 0.44% | 0.02 | $57.18 | $420,725,000 | SEC |
| 2013 Q1 | 7,325,600 | 4.53 | Add 1.43% | 0.06 | $54.99 | $402,835,000 | SEC |
| 2012 Q4 | 7,222,500 | 4.38 | Reduce 7.20% | 0.35 | $48.35 | $349,208,000 | SEC |
| 2012 Q3 | 7,782,900 | 4.80 | Reduce 4.19% | 0.21 | $48.42 | $376,848,000 | SEC |
| 2012 Q2 | 8,122,900 | 4.98 | Add 0.29% | 0.01 | $46.73 | $379,583,000 | SEC |
| 2012 Q1 | 8,099,700 | 5.18 | Reduce 2.39% | 0.12 | $44.80 | $362,867,000 | SEC |
| 2011 Q4 | 8,297,800 | 5.23 | Add 2.92% | 0.15 | $40.78 | $338,384,000 | SEC |
| 2011 Q3 | 8,062,300 | 4.93 | Add 18.07% | 0.75 | $33.58 | $270,732,000 | SEC |
| 2011 Q2 | 6,828,300 | 4.25 | Add 0.49% | 0.02 | $37.58 | $256,607,000 | SEC |
| 2011 Q1 | 6,795,300 | 5.26 | Add 38.27% | 1.46 | $34.32 | $233,215,000 | SEC |
| 2010 Q4 | 4,914,485 | 4.57 | Add 701.19% | 4.00 | $34.77 | $170,877,000 | SEC |
| 2010 Q3 | 613,400 | 0.61 | Add 1.12% | <0.01 | $31.47 | $19,304,000 | SEC |
| 2010 Q2 | 606,600 | 0.71 | $29.32 | $17,786,000 | SEC | ||
| 2010 Q1 | 606,600 | 0.78 | Buy | 0.78 | $36.56 | $22,177,000 | SEC |